World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
47973
World Ranking
6968
National Ranking
679

Overview

Simon Travis is affiliated with the University of Oxford in the United Kingdom. Their research spans multiple fields within medicine and biological sciences, particularly focusing on areas related to gastrointestinal diseases and immunology.

The main fields of study in their work include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their research also covers several subfields, notably:

  • Genetics
  • Epidemiology
  • Surgery
  • Gastroenterology
  • Immunology

Simon Travis has contributed extensively to topics involving inflammatory and gastrointestinal conditions. Key topics in their publications include:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Eosinophilic Esophagitis
  • Celiac Disease Research and Management
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Helicobacter pylori-related gastroenterology studies
  • Immunodeficiency and Autoimmune Disorders

Their frequent co-authors include:

  • Remo Panaccione
  • Marla C. Dubinsky
  • Alison Potts Bleakman
  • Theresa Hunter
  • Toshifumi Hibi∥

Simon Travis has published regularly in several venues that are central to their field. These include:

  • Journal of Crohn's and Colitis
  • Gastroenterology
  • The American Journal of Gastroenterology
  • Inflammatory Bowel Diseases
  • Poster presentations

Among their recent papers are the following influential works:

  • Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension, 2020, Gut
  • IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies, 2021, Nature Medicine
  • Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease, 2020, Gastroenterology
  • Interferon-Gamma-Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-Colitis, 2021, Gastroenterology
  • Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD, 2021, Gastroenterology

Best Publications

  • Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

    L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch

  • The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

    A. Dignass;G. Van Assche;J.O. Lindsay;M. Lémann

  • Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

    Wolfgang Hueber;Bruce E Sands;Steve Lewitzky;Marc Vandemeulebroecke

  • Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

    Axel Dignass;James O. Lindsay;Andreas Sturm;Alastair Windsor

  • The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

    Gert Van Assche;Axel Dignass;Julian Panes;Laurent Beaugerie

  • The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

    Gert Van Assche;Axel Dignass;Walter Reinisch;C. Janneke van der Woude

  • Second European Evidence-Based Consensus on the Diagnosis and Management of Ulcerative Colitis Part 1: Definitions and Diagnosis

    Axel Dignass;Rami Eliakim;Fernando Magro;Christian Maaser

  • Mucosal healing in inflammatory bowel diseases: a systematic review

    Markus F Neurath;Simon P L Travis

  • Predicting outcome in severe ulcerative colitis.

    S. P. L. Travis;J. M. Farrant;C. Ricketts;D. J. Nolan

  • Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

    Jean Frederic Colombel;Remo Panaccione;Peter Bossuyt;Milan Lukas

  • A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21

    David A. van Heel;Lude Franke;Karen A. Hunt;Rhian Gwilliam

  • Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease

    N R West;A N Hegazy;Owens Bmj.;S J Bullers

  • The diagnostic approach to monogenic very early onset inflammatory bowel disease.

    Holm H. Uhlig;Tobias Schwerd;Sibylle Koletzko;Neil Shah;Neil Shah

  • European evidence-based Consensus on the management of ulcerative colitis: Current management.

    S. P. L Travis;E. F Stange;M Lemann;T Oresland

  • Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit

    Sarah A Hearnshaw;Richard F A Logan;Derek Lowe;Simon P L Travis

  • European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

    E. F. Stange;S. P. L. Travis;S. Vermeire;W. Reinisch

  • IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease

    Alessandra Geremia;Carolina V. Arancibia-Cárcamo;Myles P.P. Fleming;Nigel Rust

  • Development of the Crohn's disease digestive damage score, the Lémann score†‡§

    Benjamin Pariente;Jacques Cosnes;Silvio Danese;William J. Sandborn

  • Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

    Simon P L Travis;Dan Schnell;Piotr Krzeski;Maria T Abreu

  • Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases

    Christoph Gasche;Arnold Berstad;Ragnar Befrits;Christoph Beglinger

Frequent Co-Authors

William J. Sandborn
William J. Sandborn University of California, San Diego
Walter Reinisch
Walter Reinisch Medical University of Vienna
Brian G. Feagan
Brian G. Feagan University of Western Ontario
Silvio Danese
Silvio Danese Vita-Salute San Raffaele University
Jean-Frederic Colombel
Jean-Frederic Colombel Icahn School of Medicine at Mount Sinai
Remo Panaccione
Remo Panaccione University of Calgary
Laurent Peyrin-Biroulet
Laurent Peyrin-Biroulet University of Lorraine
Geert R. D'Haens
Geert R. D'Haens University of Amsterdam
Michael F. Murphy
Michael F. Murphy NHS Blood and Transplant
Julián Panés
Julián Panés University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine, there are several alternative degrees and career pathways available online. Many students begin their healthcare journey through nursing programs, which offer flexibility and affordability.

For those seeking a fast track into the field, cheapest online accelerated bsn programs let you earn a bachelor’s degree in nursing quickly—ideal for career changers or those with previous college credits. If you’re already a registered nurse, you might want to explore what is the cheapest rn to bsn program online to advance your credentials and expand your career options without breaking the bank.

For the ambitious, an advanced degree can open doors to teaching or executive roles. Consider the opportunities available through doctorate in nursing education online programs, which allow you to engage in nursing leadership and academia from anywhere.

Even if you don’t have a background in nursing, there are direct entry msn programs for non-nursing majors that provide a streamlined path for individuals from diverse fields to enter advanced practice nursing.

Best Scientists Citing Simon Travis

Trending Scientists

Recently Published Articles